ArticlePloS one2017

Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice.

Luis Gustavo Modelli de Andrade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.